Emergent BioSolutions, Inc. (P) vs EmerRx Biopharma, LLC (D)
Pending
Oppositions
Proceeding Details
Proceeding Number
Filing Date
Feb 20, 2026
Last Status Update
Feb 20, 2026
Interlocutory Attorney
JILL M MCCORMACK
Parties
Plaintiff
Emergent BioSolutions, Inc.




300 N. LASALLE DRIVE, SUITE 2500
CHICAGO, IL 60654
Attorney / Correspondent:
Marks:
EMERGENT
Registered
|Reg #: 5211622|S/N: 86738042
EMERGENT
LIVE - REGISTERED
Service MarkWordOwner: Emergent BioSolutions Inc.
Status: SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Record Details
Serial No.
86738042
Registration No.
5211622
Status
LIVE
Important Dates
Filed
Aug 26, 2015
Registered
May 30, 2017
First Use
Mar 4, 2014
Goods & Services
Class 040
contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials, commercial manufacturing and lyophilization, namely, freeze-drying services for others, in the field of pharmaceuticals
EMERGENT
Registered
|Reg #: 7819389|S/N: 90888994
EMERGENT
LIVE - REGISTERED
TrademarkStylizedOwner: Emergent BioSolutions Inc.
Status: REGISTERED
Record Details
Serial No.
90888994
Registration No.
7819389
Status
LIVE
Important Dates
Filed
Aug 18, 2021
Registered
Jun 3, 2025
First Use
May 24, 2022
Goods & Services
Class 005Class 010
Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials, commercial manufacturing for others and lyophilization, namely, freeze-drying services for others, in the field of pharmaceuticals; Pharmaceutical preparations for the treatment and prophylaxis of biological infection, exposure, and contamination; pharmaceutical preparations for the treatment and prophylaxis of chemical, radiological and nuclear exposure and contamination; pharmaceutical preparations for the treatment and prophylaxis of infectious diseases; pharmaceutical products for use in biodefense, namely, pharmaceutical preparations to protect people against the effects of biological agents or bioterrorism; Research and development in the pharmaceutical, biotechnology, and biodefense fields; Research and development of pharmaceutical preparations and medicines as a Contract Development Manufacturing Operation
EMERGENT BIOSOLUTIONS
Registered
|Reg #: 3446708|S/N: 78778135
EMERGENT BIOSOLUTIONS
LIVE - REGISTERED
TrademarkWordOwner: Emergent BioSolutions Inc.
Status: REGISTERED AND RENEWED
Record Details
Serial No.
78778135
Registration No.
3446708
Status
LIVE
Important Dates
Filed
Dec 21, 2005
Registered
Jun 10, 2008
First Use
Jun 29, 2007
Goods & Services
Class 005
Pharmaceutical preparations, namely, vaccines, immunotherapeutics, biologics, and immunobiotics for prophylactic therapeutic purposes for the treatment of infectious diseases and disorders related to infectious diseases
EMERGENT
Registered
|Reg #: 7225115|S/N: 88884324
EMERGENT
LIVE - REGISTERED
TrademarkWordOwner: Emergent BioSolutions Inc.
Status: REGISTERED
Record Details
Serial No.
88884324
Registration No.
7225115
Status
LIVE
Important Dates
Filed
Apr 23, 2020
Registered
Nov 21, 2023
First Use
Jun 29, 2007
Goods & Services
Class 005
Pharmaceutical preparations for the treatment and prophylaxis of biological infection, exposure, and contamination; pharmaceutical preparations for the treatment and prophylaxis of chemical, radiological and nuclear exposure and contamination; pharmaceutical preparations for the treatment and prophylaxis of infectious diseases; pharmaceutical products for use in biodefense | Research and development in the pharmaceutical, biotechnology, and biodefense fields; Research and development of pharmaceutical preparations and medicines as a Contract Development Manufacturing Operation
EMERGENT
Registered
|Reg #: 7819388|S/N: 90888990
EMERGENT
LIVE - REGISTERED
TrademarkStylizedOwner: Emergent BioSolutions Inc.
Status: REGISTERED
Record Details
Serial No.
90888990
Registration No.
7819388
Status
LIVE
Important Dates
Filed
Aug 18, 2021
Registered
Jun 3, 2025
First Use
May 24, 2022
Goods & Services
Class 005Class 010
Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials, commercial manufacturing for others and lyophilization, namely, freeze-drying services for others, in the field of pharmaceuticals; Pharmaceutical preparations for the treatment and prophylaxis of biological infection, exposure, and contamination; pharmaceutical preparations for the treatment and prophylaxis of chemical, radiological and nuclear exposure and contamination; pharmaceutical preparations for the treatment and prophylaxis of infectious diseases; pharmaceutical products for use in biodefense, namely, pharmaceutical preparations to protect people against the effects of biological agents or bioterrorism; Research and development in the pharmaceutical, biotechnology, and biodefense fields; Research and development of pharmaceutical preparations and medicines as a Contract Development Manufacturing Operation
VS
Defendant
EmerRx Biopharma, LLC
1000 ATLANTIC AVE SUITE 110
ALAMEDA, CA 94501
Attorney / Correspondent:
Mark:
EMERRX BIOPHARMA
Pending
S/N: 99174025
EMERRX BIOPHARMA
LIVE - PENDING
TrademarkWordOwner: EmerRx Biopharma, LLC
Status: OPPOSITION PENDING
Record Details
Serial No.
99174025
Status
LIVE
Important Dates
Filed
May 7, 2025
First Use
Apr 1, 2025
Goods & Services
Class 005
Pharmaceutical preparations for the treatment and prevention of opioid overdose; Pharmaceutical preparations for intranasal naloxone for the treatment and reversal of opioid overdose; Pharmaceutical preparations for the treatment of opioid overdose; Drug delivery agents in the form of intranasal sprays that facilitate the delivery of pharmaceutical preparations
TTAB Documents
Title | Date | Entry # | Category | Code | Actions |
|---|---|---|---|---|---|
INSTITUTED | Feb 20, 2026 | 3 | Status | 128 | |
NOTICE AND TRIAL DATES SENT; ANSWER DUE: | Feb 20, 2026 | 2 | Scheduling | 707 | |
FILED AND FEE | Feb 20, 2026 | 1 | Fees | 124 |